SCHEMBL5040847

SCHEMBL5040847

COC(C(=O)NCc1ccc(C#N)cc1)c1ccc(-c2ccccc2)cc1F

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PKM P14618 1/20 0.47
HIF1A Q16665 1/20 0.42
FFAR1 O14842 1/20 0.42
SLC1A3 P43003 1/20 0.42
SLC1A2 P43004 1/20 0.42
PPARA Q07869 1/20 0.42
SCN5A Q14524 1/20 0.41
SCN9A Q15858 1/20 0.41
BACE1 P56817 3/20 0.40
MMP2 P08253 1/20 0.40
MMP3 P08254 1/20 0.40
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
HDAC1 Q13547 1/20 0.39
AKR1C3 P42330 1/20 0.39
HMGCR P04035 2/20 0.39
ABCB1 P08183 1/20 0.39
HPGD P15428 1/20 0.39
ABCG2 Q9UNQ0 1/20 0.39
CNR2 P34972 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5040855 1.00 PKM (0.47) PKMHIF1AFFAR1SLC1A3SLC1A2
SCHEMBL5040859 0.92 PKM (0.47) PKMHIF1ASLC1A3SLC1A2PPARA
SCHEMBL5040862 0.92 PKM (0.47) PKMHIF1ASLC1A3SLC1A2PPARA
SCHEMBL5042135 0.91 POLB (0.48) HIF1APPARAMMP2MMP3NPC1
SCHEMBL5042138 0.91 POLB (0.48) HIF1APPARAMMP2MMP3NPC1
SCHEMBL5042308 0.91 DGAT2 (0.44) PKMHIF1ARAB9AEP300
SCHEMBL5042310 0.91 DGAT2 (0.44) PKMHIF1ARAB9AEP300
SCHEMBL5045223 0.90 GSK3B (0.41) PKMHIF1APPARASCN9AMMP2
SCHEMBL5045219 0.90 GSK3B (0.41) PKMHIF1APPARASCN9AMMP2
SCHEMBL5043045 0.89 CSF1R (0.38) PKMHIF1APPARAMMP2MMP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1567498-B1 MANDELIC ACID DERIVATIVES HOFFMANN LA ROCHE (CH) 2008-01-23 EP disclosed
US-7129238-B2 Mandelic acid derivatives HOFFMANN-LA ROCHE INC. (US) 2006-10-31 US disclosed
EP-1567498-A2 MANDELIC ACID DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2005-08-31 EP disclosed
US-20040122057-A1 Novel mandelic acid derivatives HOFFMANN-LA ROCHE INC. 2004-06-24 US disclosed
WO-2004048335-A2 MANDELIC ACID DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2004-06-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040122057-A1 Novel mandelic acid derivatives F7, F11, F9 PKM 4225/4885HIF1A 251/4885FFAR1 1355/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.